* Bausch Health Companies Inc BHC.TO is expected to show
a rise
in quarterly revenue when it reports results on August 3.
* The Laval Quebec-based company is expected to report a
3.7% increase in revenue to $2.04 billion from $1.97 billion a
year ago, according to the mean estimate from 4 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Bausch Health
Companies
Inc is for earnings of 73 cents per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Bausch
Health
Companies Inc is $8.75, below its last closing price
of C$12.82.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Mar. 31 2023 0.73 0.72 0.52 Missed -27.6
Dec. 31 2023 0.92 0.91 1.03 Beat 13.7
Sep. 30 2022 0.84 0.87 0.76 Missed -12.6
Jun. 30 2022 0.89 0.89 0.56 Missed -37.3
Mar. 1.00 1.03 0.73 Missed -28.9
31 2022
Dec. 31 2021 1.12 1.11 1.28 Beat 15
Sep. 30 2021 1.04 1.04 1.16 Beat 11
Jun. 30 2021 0.98 0.98 0.97 Missed -1
This summary was machine generated August 1 at 13:34 GMT. All
figures in US dollars unless otherwise stated